Receiving Orphan Drug Designation is an important milestone in the clinical development of CK0804 for myelofibrosis
Greenko ZeroC will supply Carbon Free Energy and enable Green Hydrogen along with its various chemical derivatives.
He is a seasoned leader with 34 years of rich and diverse experience across geographies and consumer facing companies such as Xerox India and Bharti Airtel
Large datasets will train machine learning models and speed up agile discovery of novel crop protection solutions
CLNK is a biotechnology research and development company that utilizes umbilical cord blood as the raw material to develop innovative, allogeneic, off-the-shelf, cell based therapeutic products
India plays a critical role in Bristol Myers Squibb’s global strategy
Cobenfy generated $43 million in third-quarter sales, up from $35 million in the second quarter
The INSPIRE-1 and INSPIRE-2 trials are Phase 3 studies assessing the efficacy and safety of tildrakizumab 100 mg (ILUMYA) in adults with active psoriatic arthritis (PsA)
Subscribe To Our Newsletter & Stay Updated
